Thursday, December 5, 2024
HomeTagsBiomunex

Biomunex

Ipsen & Biomunex Ink Exclusive Licensing Deal for MAIT Cell Engager

Ipsen and Biomunex Pharmaceuticals announced an exclusive global licensing agreement for BMX-502. BMX-502 is a bispecific antibody that engages and activates a subset of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics